Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today reported financial results for the third quarter ended September 30, 2014 and provided an update on recent corporate events.
“Since joining Synta two months ago, I have been working closely with the Board and management team to develop a strategy for leveraging the talent within Synta along with external partnerships to realize the tremendous value-potential in ganetespib, our HDC platform and other pipeline assets,” said Anne Whitaker, President and Chief Executive Officer of Synta.
Help employers find you! Check out all the jobs and post your resume.
